StockData
INISOTCIndustrial Instruments For Measurement, Display, and ControlFiscal year ends December 31

RADNOSTIX INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.05−0.00 (-6.00%)

Close on Oct 19, 2026

Market cap
$24.87M
P/E (TTM)
–
Dividend yield
–

RADNOSTIX INC revenue by segment

By business segment

RevenueQ2 26Q1 26Q4 25Q3 25Q2 25Q1 25Q4 24Q3 24Q2 24Q1 24Q4 23Q3 23% of revenueYoY
Theranostics Products [Member]$1.08M$1.40M$1.66M$1.48M$1.91M$1.79M$1.75M$2.18M$2.17M$1.91M$1.81M$1.53M40.4%-43.4%
Calibration & Reference Products [Member]$1.06M$882.79K$946.40K$961.09K$1.01M$1.33M$1.42M$926.40K––––39.5%+4.1%
Cobalt Products [Member]$497.67K$9.74K$235.07K$766.68K$678.02K$72.45K$724.56K$814.85K$592.20K$233.97K$101.53K$328.98K18.6%-26.6%
Medical Device Products [Member]$40.96K$89.11K$52.48K$65.76K$58.09K$52.63K$8.66K$0$0$0$0$01.5%-29.5%
Fluorine Products [Member]$0$0$0$0$0$0$0$0$0$0$0$00.0%–
Radiochemical Products [Member]–––––––––––$1.53M––
Nuclear Medicine Products [Member]––––$1.01M$1.33M$1.42M$926.40K$407.90K$765.41K$1.24M$1.05M––

By product or service

By region

RevenueQ2 26Q1 26Q4 25Q3 25Q2 25Q1 25Q4 24Q3 24Q2 24Q1 24Q4 23Q3 23% of revenueYoY
Non-US [Member]–––––––$374.93K$319.70K$406.34K$1.03M$383.22K––
United States–––––––$3.55M$2.85M$2.50M$2.12M$2.54M––

From the segment and revenue-disaggregation notes of Radnostix's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.